![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, July 10, 2014 10:28:19 AM
I agree, it is a pretty long wait for most companies in other industries to show growth and revenue. However, one has to take into consideration the industry overall IMO. This isn't just a "product based" company, it is a R&D company delving into a field that has only some 50+ years since it's inception with plenty of controversy stunning its advances from day1 in political and social fronts IMO. In any other industry 15yrs of minimal/no growth may be considered a failure. This industry however is a monster of its own nature IMO.
As for your question: it took Medical Development Corporation from 1957 to 1996 to join Johnson&Johnson under the new name Cordis Corporation. What took it there was not the MM but the science IMO. So as I said before, financial assessment may indicate one thing, but science isn't always dictated by finance alone IMHO.
DD and GLTA BIOHEART!!!
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM